Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER Study

NACompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 31, 2016

Study Completion Date

May 31, 2018

Conditions
Acute ST Segment Elevation Myocardial Infarction
Interventions
DEVICE

PCI in patients with ST-elevation myocardial infarction

Percutaneous coronary intervention in patients with ST segment elevation myocardial infarction (STEMI)

DEVICE

PCI in patients with ST-elevation myocardial infarction

Percutaneous coronary intervention in patients with ST-segment elevatio myocardial infarction

Trial Locations (13)

1000

PHE University Cardiology clinic, Skopje

50134

Azienda Ospedaliero Universitaria Careggi, Florence

Unknown

Instituto Dante Pazzanese, São Paulo

"Azienda Ospedaliero Universitaria, Policlinico Vittorio Emanuele - Ospedale Ferrarotto", Catania

Cardiologico Monzino, Milan

San Raffaele Hospital, Milan

Clinical Center of Serbia, Belgrade

Clinical Hospital Center Zemun (CHC Zemun), Belgrade

Clinical center Nis (CCNIs), Niš

Complejo Hospitalario Universitario A Coruña, A Coruña

Hospital Universitario Virgen Arrixaca-Murcia, El Palmar

Hospital Universitario Central Asturias-Oviedo, Oviedo

Complejo Hospitalario Universitario Santiago de Compostela, Santiago de Compostela

All Listed Sponsors
lead

Terumo Europe N.V.

INDUSTRY

NCT02828683 - Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in STEMI Patients - MASTER Study | Biotech Hunter | Biotech Hunter